X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1461) 1461
Newsletter (140) 140
Publication (128) 128
Book Chapter (15) 15
Book Review (12) 12
Newspaper Article (9) 9
Magazine Article (3) 3
Trade Publication Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
entecavir (1421) 1421
hepatitis b (915) 915
humans (901) 901
index medicus (831) 831
lamivudine (825) 825
hepatitis b, chronic - drug therapy (665) 665
antiviral agents - therapeutic use (607) 607
gastroenterology & hepatology (583) 583
male (537) 537
female (506) 506
guanine - analogs & derivatives (496) 496
hepatitis b virus (479) 479
adult (476) 476
middle aged (466) 466
tenofovir (417) 417
treatment outcome (411) 411
chronic hepatitis b (392) 392
adefovir dipivoxil (363) 363
guanine - therapeutic use (354) 354
therapy (341) 341
hepatitis b virus - genetics (320) 320
hepatitis (314) 314
hepatitis b virus - drug effects (301) 301
adefovir (291) 291
care and treatment (291) 291
adenine - analogs & derivatives (264) 264
dna, viral - blood (257) 257
resistance (253) 253
drug therapy (233) 233
interferon (226) 226
hepatitis b, chronic - virology (223) 223
hepatocellular-carcinoma (220) 220
lamivudine - therapeutic use (216) 216
drug resistance (208) 208
health aspects (201) 201
antiviral agents (199) 199
hepatitis b e antigens - blood (199) 199
aged (193) 193
drug resistance, viral (193) 193
virology (193) 193
infection (191) 191
antiviral agents - administration & dosage (190) 190
adenine - therapeutic use (185) 185
infectious diseases (185) 185
efficacy (183) 183
viral load (183) 183
retrospective studies (181) 181
organophosphonates - therapeutic use (180) 180
cirrhosis (176) 176
pharmacology & pharmacy (174) 174
management (173) 173
telbivudine (172) 172
tenofovir disoproxil fumarate (171) 171
antiviral agents - adverse effects (159) 159
drug therapy, combination (157) 157
research (157) 157
mutation (154) 154
risk (153) 153
analysis (148) 148
dna (147) 147
antiviral therapy (143) 143
virus infection (143) 143
antiviral agents - pharmacology (140) 140
deoxyribonucleic acid--dna (138) 138
hepatology (138) 138
time factors (138) 138
hbv (137) 137
young adult (137) 137
guanine - administration & dosage (134) 134
liver (130) 130
liver cirrhosis (128) 128
medicine & public health (127) 127
hepatitis b, chronic - complications (124) 124
hepatitis b - drug therapy (122) 122
hepatocellular carcinoma (121) 121
virus diseases (118) 118
antigens (116) 116
risk factors (116) 116
virus (116) 116
gastroenterology and hepatology (113) 113
hepatitis b, chronic - diagnosis (110) 110
genotype (109) 109
lamivudine therapy (107) 107
liver cancer (103) 103
natural-history (103) 103
patients (103) 103
hepatitis b, chronic - blood (100) 100
drug resistance, viral - genetics (97) 97
liver diseases (97) 97
nucleoside analogs (96) 96
combination (94) 94
digestive system diseases (94) 94
safety (92) 92
thymidine - analogs & derivatives (92) 92
hepatitis b virus - immunology (91) 91
hepatitis b surface antigens - blood (89) 89
lamivudine treatment (89) 89
dosage and administration (88) 88
alanine transaminase - blood (86) 86
combination therapy (86) 86
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1460) 1460
Korean (118) 118
French (13) 13
Spanish (13) 13
German (7) 7
Japanese (3) 3
Portuguese (3) 3
Turkish (3) 3
Chinese (2) 2
Hungarian (2) 2
Russian (2) 2
Arabic (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Hepatology International, ISSN 1936-0533, 6/2008, Volume 2, Issue 2, pp. 147 - 151
Antiviral resistance is now the single most important factor in treatment failure using nucleos(t)ide analogues (NA). Primary drug resistance mutations refer... 
Medicine & Public Health | Colorectal Surgery | Surgery | Hepatology | ENTECAVIR | VIRUS | MANAGEMENT | CHRONIC HEPATITIS-B | ADEFOVIR DIPIVOXIL | POLYMERASE | LAMIVUDINE THERAPY | SELECTION | GASTROENTEROLOGY & HEPATOLOGY | Genetic aspects | Research | Hepatitis B virus | Drug resistance | Health aspects | Human immunodeficiency virus--HIV | Mutation
Journal Article
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 08/2018, Volume 52, Issue 2, pp. 201 - 209
Journal Article
Antiviral Research, ISSN 0166-3542, 07/2017, Volume 143, pp. 62 - 68
Journal Article